Jennifer Hu is a Scientist at Bristol Myers Squibb where she specializes in analytical strategy and method development for cell therapies and vector products. Before joining BMS, she worked on various facets of process and analytical development of protein-based therapeutics at Genentech. Jennifer holds a PhD in Biological Chemistry from MIT.

Jennifer Hu

Characterization of DNA Impurities in Cell Therapies
Wednesday, February 24, 2021
T cells play important roles in adaptive immunity by serving as sentinels against foreign pathogens. T cells that have been engineered to recognize cancer-specific antigens present a promising treatment option for a number of... read more